SCHEDULE: BlackRock Affirms Significant 14.4% Stake in Balchem Corp
Beneficial Ownership Report
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 14.4% of Balchem Corp's common stock as of June 30, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 4,688,457 shares of Balchem Corp's common stock.
- This represents 14.4% of the total outstanding common stock of Balchem Corp.
- BlackRock, Inc. holds sole voting power over 4,625,783 shares and sole dispositive power over 4,688,457 shares.
- The filing is an Amendment No. 4 to Schedule 13G, indicating a previous disclosure of ownership.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Balchem Corp.
- iShares Core S&P Small-Cap ETF, a fund managed by BlackRock, holds more than five percent of Balchem Corp's total outstanding common stock.
Sentiment
Score: 7
Explanation: The disclosure of a significant and stable institutional ownership by a major asset manager like BlackRock is generally a positive signal, indicating confidence in the company and its inclusion in broad market indices.
Positives
- BlackRock's significant 14.4% beneficial ownership stake in Balchem Corp indicates strong institutional confidence in the company.
- The holding is stated to be in the ordinary course of business, suggesting a stable, long-term investment rather than an activist position.
Risks
- No specific risks related to Balchem Corp's operations or financial health are disclosed in this ownership filing.
Future Outlook
This Schedule 13G filing does not provide any forward-looking statements or guidance regarding Balchem Corp's future performance or outlook.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
Industry Context
BlackRock, Inc. is one of the world's largest asset managers, and its significant holdings in publicly traded companies like Balchem Corp are typical for a firm that manages numerous index funds and ETFs, such as the iShares Core S&P Small-Cap ETF mentioned in the filing. This indicates Balchem Corp's inclusion in relevant market indices, reflecting its position within the broader market.
Comparison to Industry Standards
- BlackRock's substantial ownership stake is consistent with its role as a major institutional investor and manager of passive investment vehicles like index funds. For example, the iShares Core S&P Small-Cap ETF, which holds over 5% of Balchem Corp, aims to replicate the performance of a specific market index, meaning Balchem Corp is likely a component of that index.
- Large institutional ownership, such as that disclosed by BlackRock, is a common characteristic of publicly traded companies, often viewed positively as it can provide stability and liquidity to the stock.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact | Multiple individuals under Power of Attorney dated April 30, 2023 | Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg and Brenda Schulz (acting severally) | 01/21/2025 | Issuance of a new Power of Attorney by BlackRock, Inc., expressly revoking the previous one. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Policy/Authorization Update | BlackRock, Inc. updated its Power of Attorney, authorizing specific individuals to execute ownership or control-person reporting requirements for various regulatory bodies, including the SEC. | 01/21/2025 | Streamlines compliance with regulatory reporting requirements for BlackRock, Inc. and its subsidiaries. |
Related Party Transactions
- iShares Core S&P Small-Cap ETF, a fund managed by BlackRock, Inc., is identified as having an interest of more than five percent of the total outstanding common stock of Balchem Corp. This represents a related party holding within BlackRock's broader asset management structure.
Stakeholder Impact
- Shareholders: The significant institutional holding by BlackRock may enhance investor confidence and potentially improve stock liquidity.
- Management: The stable, non-control-seeking nature of BlackRock's investment suggests no immediate pressure for strategic or operational changes from this shareholder.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Date of previous Power of Attorney revoked by BlackRock, Inc. |
| 01/21/2025 | Effective date of the new Power of Attorney granted by BlackRock, Inc. |
| 06/30/2025 | Date of event which requires the filing of this statement. |
| 07/18/2025 | Date of filing of this Schedule 13G Amendment No. 4. |
Keywords
BlackRock, Balchem Corp, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management, iShares, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.